ATCC determines the biosafety level of a material based on our risk assessment as guided by the current edition of Biosafety in Microbiological and Biomedical Laboratories (BMBL), U.S. Department of Health and Human Services.

人肺癌细胞NCI-H292 [H292]说明书 于一名32 岁黑人女性。此细胞株源自肺粘液� �皮癌的淋巴结转移灶。 这个细胞系最初用化学合成培养基(HITES) 分离获得, 后期培养转换

TANK cells show reactivity with human alloantisera specific for the HLA A1, A3, A10, A19, B12, B17, B22 and B40 cross-reactive groups. The cells retain their mucoepidermoid characteristics in culture as determined by their ultrastructure and expression of multiple markers of …

NCI-H292细胞系源自肺粘液表皮样癌（也称为肺粘液上皮样癌）的淋巴结转移，最初从一名32岁的黑人女性患者的淋巴结转移部位分离。 NCI-H292细胞具有上皮细胞样的形态，呈贴壁生长，并在亚显微结构上保留了粘膜上皮细胞的特征。 NCI-H292细胞对乙型肝炎病毒（HBV）具有易感性，能够支持HBV的生长。 NCI-H292细胞是一个染色体计数接近二倍体的人类细胞系。 模式染色体数目为47，出现在36%的细胞中。 倍体计数较高的细胞率为3.9%。 大多数细胞共有12个标记 …

Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification. Signatures of mutation and …

Cell information for NCI-H292. Find diseases associated with this biological target and compounds tested against it in bioassay experiments.

一、 细胞名称: 人肺癌细胞( 淋巴结转移) NCI-H292 (目录号: TCHu122) 二、 完全培养基配制:RPMI 1640 培养基(GIBCO 货号:11875093),90%; 优质胎牛血清,10%

82 细胞名称:NCI-H292 [H292] 细胞描述:人肺癌细胞NCI-H292 [H292] 来. 源于一名32岁黑人女性。此细胞株源自肺粘液�. 皮癌的淋巴结转移灶。这个细胞系最初用化学合成培养基(HITES)分离获得,后期培养转换�. 含血清的培养基培养。此细胞在培养时保留了粘膜上皮细胞的特性,表达鳞状分化的多种标记,如细胞角蛋白 (keratin)、波形蛋白(vimentin )、粘蛋白胭脂红(mucicarmine)阳性,而神经丝三联体蛋白(neurofi. ament triplet protein)阴�.

5 天之前 · NCI-H292细胞支持HBV的生长，左旋多巴脱羧酶阴性。 NCI-H292细胞可以作为筛选模型，将人类亚基因组片段转染入细胞来研究HBV及其自身基因在病毒性肝炎和肝癌发生中的作用。

NCI-H292 是来源于人粘液表皮样肺癌细胞系,在 M-NSG 小鼠皮下接种后,能正常成瘤。 Description *Literature published using this strain should indicate: NCI-H292 cell line (Cat. NO. NM-F13) was purchased from Shanghai Model Organisms Center, Inc.. Figure 1. Tumor growth curve of NCI-H292 xenograft model (n=5) Figure 2. Body weight change of NCI-H292 xenograft model (n=5)